论文信息 - A phase Ib study of pembrolizumab (pembro) plus trastuzumab emtansine (T-DM1) for metastatic HER2+ breast cancer (MBC). - 字舞流文

A phase Ib study of pembrolizumab (pembro) plus trastuzumab emtansine (T-DM1) for metastatic HER2+ breast cancer (MBC).

E. Winer | B. Overmoyer | E. Mittendorf | J. Agudo | E. Allen | Edward T. Richardson | S. Tolaney | I. Krop | N. Tayob | G. Wulf | A. Waks | T. Keenan | Tianyu Li